Page last updated: 2024-09-03

tryptophan methyl ester and u-50488

tryptophan methyl ester has been researched along with u-50488 in 1 studies

Compound Research Comparison

Studies
(tryptophan methyl ester)
Trials
(tryptophan methyl ester)
Recent Studies (post-2010)
(tryptophan methyl ester)
Studies
(u-50488)
Trials
(u-50488)
Recent Studies (post-2010) (u-50488)
1151351,6643209

Protein Interaction Comparison

ProteinTaxonomytryptophan methyl ester (IC50)u-50488 (IC50)
Delta-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorMus musculus (house mouse)0.0027
Mu-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.7171
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0958
Kappa-type opioid receptorHomo sapiens (human)0.0537

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barjavel, MJ; Bhargava, HN; Thorat, SN1

Other Studies

1 other study(ies) available for tryptophan methyl ester and u-50488

ArticleYear
Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
    European journal of pharmacology, 1994, Jun-13, Volume: 258, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Dose-Response Relationship, Drug; Drug Synergism; Male; Mice; Pain Measurement; Pyrrolidines; Receptors, Opioid, kappa; Tryptophan; Tyrosine

1994